Several studies have shown that in AD early stages, abnormal and continuous activation of PI3K/Akt/mTOR signaling occurs, with increased phosphorylation of mTOR, contributing to disease progression and cognitive decline (Bhaskar et al., 2009; O’neill, 2013). Here, AKT1 is linked to Alzheimer disease.